CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the genetic mutations that drive cancer, specifically melanoma, using advanced genomic technologies. The aim is to identify targetable mutations and understand their functional effects to improve treatment strategies.
Cancer is a genetic disease that involves the accumulation of somatic mutations.
Comprehensive understanding of the mutations that cause cancer and their functional effects is a critical step towards: a) global understanding of cancer development and tumor phenotypes, b) sub-classification of cancer based on mutational signatures, and c) developing targeted therapies based on mutations in specific tumors.Recent advances in high-throughput genomic technologies provide an unprecedented opportunity…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
